0 84

Cited 9 times in

CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation

 ANTICANCER RESEARCH, Vol.37(6) : 3249-3258, 2017 
Journal Title
Issue Date
Adult ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics* ; DNA Mutational Analysis/methods* ; Female ; Genetic Predisposition to Disease ; Humans ; Immunohistochemistry ; Neoplasms, Cystic, Mucinous, and Serous/chemistry ; Neoplasms, Cystic, Mucinous, and Serous/genetics* ; Neoplasms, Cystic, Mucinous, and Serous/pathology ; Neoplasms, Cystic, Mucinous, and Serous/surgery ; Ovarian Neoplasms/chemistry ; Ovarian Neoplasms/genetics* ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/surgery ; Phenotype ; Point Mutation* ; Sequence Deletion* ; Sex Cord-Gonadal Stromal Tumors/chemistry ; Sex Cord-Gonadal Stromal Tumors/genetics* ; Sex Cord-Gonadal Stromal Tumors/pathology ; Sex Cord-Gonadal Stromal Tumors/surgery ; beta Catenin/genetics*
BACKGROUND/AIM: Microcystic stromal tumor (MCST) is a rare stromal tumor of the ovary. In this study, we describe clinicopathological characteristics and results of mutational analyses of the CTNNB1gene in two cases of ovarian MCST and we provide a thorough review of previously published cases alongside our current cases and clarify the clinicopathological characteristics of ovarian MCST. PATIENTS AND METHODS: Patients' age was 33 and 31 years, respectively. One patient presented with fever and low abdominal pain, whereas a pelvic mass was incidentally detected in another patient. Grossly, the cut surface of the tumors was mixed solid and cystic. RESULTS: Histologically, the tumor characteristically displayed numerous microcysts, solid cellular areas, and intervening hyalinized stroma. Areas of moderate-to-severe nuclear pleomorphism with occasional multinucleated giant cells and bizarre nuclei were noted in one of the two cases. Immunohistochemically, both cases demonstrated diffuse and strong β-catenin expression in the nuclei and the cytoplasm. The tumor cells were also diffusely positive for CD10, vimentin, Wilms tumor 1, and cyclin D1. The tumor cells were consistently negative for E-cadherin, inhibin-α, calretinin, estrogen receptor, and progesterone receptor. Mutational analyses using direct sequencing and pyrosequencing methods exhibited a single nucleotide mutation in CTNNB1 exon 3 (c.122C>T) in one case. We also found a novel deletion mutation in the same exon (c.88_99delTACCTGGACTCT) in another case. CONCLUSION: We demonstrated a previously reported CTNNB1 point-mutation using pyrosequencing and a novel deletion mutation in ovarian MCSTs. The review of the literature of previously published cases in combination with our current cases clarifies the clinicopathological characteristics of ovarian MCST and the comprehensive analysis of these cases would expand our knowledge regarding ovarian MCST.
Full Text
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
Yonsei Authors
Kim, Eun Kyung(김은경)
Kim, Hyun-Soo(김현수)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.